key: cord-1001776-9fa2h855 authors: Oladunni, Fatai S.; Park, Jun-Gyu; Tamayo, Paula Pino; Gonzalez, Olga; Akhter, Anwari; Allué-Guardia, Anna; Olmo-Fontánez, Angélica; Gautam, Shalini; Garcia-Vilanova, Andreu; Ye, Chengjin; Chiem, Kevin; Headley, Colwyn; Dwivedi, Varun; Parodi, Laura M.; Alfson, Kendra J.; Staples, Hilary M.; Schami, Alyssa; Garcia, Juan I.; Whigham, Alison; Platt, Roy Neal; Gazi, Michal; Martinez, Jesse; Chuba, Colin; Earley, Stephanie; Rodriguez, Oscar H; Mdaki, Stephanie Davis; Kavelish, Katrina N; Escalona, Renee; Hallam, Cory R. A.; Christie, Corbett; Patterson, Jean L.; Anderson, Tim J. C.; Carrion, Ricardo; Dick, Edward J.; Hall-Ursone, Shannan; Schlesinger, Larry S.; Kaushal, Deepak; Giavedoni, Luis D.; Alvarez, Xavier; Turner, Joanne; Martinez-Sobrido, Luis; Torrelles, Jordi B. title: Lethality of SARS-CoV-2 infection in K18 human angiotensin converting enzyme 2 transgenic mice date: 2020-07-19 journal: bioRxiv DOI: 10.1101/2020.07.18.210179 sha: 9b23295faef1454c8e045d16b5f3a92707f36968 doc_id: 1001776 cord_uid: 9fa2h855 Vaccine and antiviral development against SARS-CoV-2 infection or COVID-19 disease currently lacks a validated small animal model. Here, we show that transgenic mice expressing human angiotensin converting enzyme 2 (hACE2) by the human cytokeratin 18 promoter (K18 hACE2) represent a susceptible rodent model. K18 hACE2-transgenic mice succumbed to SARS-CoV-2 infection by day 6, with virus detected in lung airway epithelium and brain. K18 ACE2-transgenic mice produced a modest TH1/2/17 cytokine storm in the lung and spleen that peaked by day 2, and an extended chemokine storm that was detected in both lungs and brain. This chemokine storm was also detected in the brain at day 4. K18 hACE2-transgenic mice are, therefore, highly susceptible to SARS-CoV-2 infection and represent a suitable animal model for the study of viral pathogenesis, and for identification and characterization of vaccines (prophylactic) and antivirals (therapeutics) for SARS-CoV-2 infection and associated severe COVID-19 disease. Mouse IFN- (Type I) and IFN- (Type III) were measured by enzyme-linked immunosorbent 182 assays (ELISA) (PBL Assay Science) following the manufacturer's recommendations, detecting 183 all 14 known IFN- subtypes and IFN- 2 and 3. 184 185 Tissues were fixed in 10% neutral buffered formalin, embedded in paraffin blocks, and sectioned 187 at 4m thickness. Sections were stained with Haemotoxylin and Eosin (H&E) and evaluated using 188 light microscopy in a blinded manner by a board certified veterinary pathologist. 189 190 Immunostaining and confocal microscopy were performed as previously described. 20 By 5-DPI, SARS-CoV-2 infected K18 hACE2 transgenic mice lost over 20% of their initial body 242 weight, were lethargic with rough fur and hunched appearance, immobile, and did not eat or drink, 243 and succumbed to the infection by 6-DPI (Figs 1A, B) . All K18 hACE2 transgenic mice 244 succumbed to infection by 6-DPI, with the exception of one that was humanely euthanized due to 245 IACUC-defined endpoints. Mock-infected K18 hACE2 transgenic or WT C57BL/6 mice, or SARS-246 CoV-2 infected WT C57BL/6 mice appeared healthy, maintained weight, and all survived SARS-247 CoV-2 infection for the duration of this study (Figs 1A, B) . Differentiating by sex, we observed 248 that SARS-CoV-2 infected male K18 hACE2 transgenic mice lost weight starting 1-DPI, at the 249 rate of approximately 5% per day whereas SARS-CoV-2 infected female K18 hACE2 transgenic 250 mice did not begin to lose weight until 3-DPI (Fig S1) . In both cases, after 3-DPI, morbidity 251 indicators accelerated until all K18 hACE2 transgenic mice, independent of sex, succumbed to 252 SARS-CoV-2 infection by 6-DPI (Fig S1) . 253 To correlate body weight loss (Fig. 1A) and survival ( Fig. 1B) with viral replication, female (n=8) 255 and male (n=8) K18 hACE2 transgenic and WT C57BL/6 mice were similarly mock-infected or 256 infected with 1x10 5 PFU of SARS-CoV-2 and euthanized at 2-or 4-DPI, to determine viral titers 257 in the nasal turbinate, trachea, lung, heart, kidney, liver, spleen, small intestine, large intestine, 258 and brain. By 2-DPI, K18 hACE2 transgenic mice had ~1x10 3 PFU in nasal turbinate and ~1x10 4 259 PFU in lung, indicating the presence of SARS-CoV-2 in both the upper and lower respiratory 260 tracts. Viral titers at both sites were maintained at 4-DPI (Figs 1C, D) . SARS-CoV-2 was also 261 detected in the brain at 4-DPI (~1x10 3 PFU) (Fig 1E) , but absent in all other organs. In all organs 262 where SARS-CoV-2 was detected (nasal turbinate, lung and brain), we observed no sex 263 differences in viral titers (Fig S2) . SARS-CoV-2 infected WT C57BL/6 mice had undetectable viral 264 loads at both DPI in all organs studied, in accordance with previous studies suggesting that WT 265 C57BL/6 mice are resistant to SARS-CoV-2 infection (Figs 1A-E, S1 and S2). 15 Taken together, 266 these results demonstrate the susceptibility of K18 hACE2 transgenic mice, but not WT C57BL/6 267 mice, to SARS-CoV-2 infection at the studied MOI, with detectable virus in the upper and lower 268 respiratory tract, and brain, at early time points post-infection. An early (2-DPI) chemokine storm was observed in the lungs of K18 hACE2 transgenic mice 273 infected with SARS-CoV-2 (Fig 2A) . MIP-2/CXCL2, MCP-1/CCL2, MIP-1/CCL3, MIP-1/CCL4, 274 RANTES/CCL5 and IP-10/CXCL10 levels were significantly increased in the lungs relative to 275 C57BL/6 WT infected mice or mock-infected K18 hACE2 transgenic mice. At 4-DPI several 276 chemokines had decreased in magnitude but were significantly elevated when compared to 277 C57BL/6 WT or mock-infected K18 hACE2 transgenic mice. For some chemokines, such as 278 RANTES/CCL5, the high levels detected in the lung at 2-DPI were sustained at 4-DPI (Fig 2A) . 279 Chemokine levels in the lungs of C57BL/6 WT mice did not increase in response to SARS-CoV-280 2 infection at either time point tested. A chemokine storm has been described in humans with 281 COVID-19 disease, and it has been associated with development of acute respiratory distress 282 syndrome (ARDS) in mice. 22 283 284 As a measure of systemic inflammation, we determined chemokine levels in the spleen, where 285 MIP-2/CXCL2, IP-10/CXCL10, MIP-1/CCL3, and MIP-1/CCL4 were significantly increased at 286 2-DPI (Fig 2B) . Only MIP-1/CCL3 and MIP-1/CCL4 maintained a significant increase at 4-DPI 287 when compared to both mock-infected K18 hACE2 transgenic mice and WT-infected C57BL/6 288 mice. Contrary to the lung, we did not observe an increase in RANTES/CCL5 relative to virus-289 infected C57BL/6 WT or mock-infected K18 hACE2 transgenic mice (Fig 2B) , identifying a 290 potential sustained lung-specific chemokine response after SARS-CoV-2 infection. Our results 291 indicate that SARS-CoV-2 infection of K18 hACE2 transgenic mice triggers both a local (lung) 292 and systemic (spleen) chemokine storm. Chemokine analysis in nasal turbinate supported the 293 early chemokine storm at 2-DPI in SARS-CoV-2 infected K18 hACE2 transgenic mice, with 294 significant but transient high levels of MCP-1/CCL2, MIP-1/CCL3, RANTES/CCL5 and IP-295 10/CXCL10 (Fig S3A) . No differences were observed in the trachea (Fig S3B) . Interestingly, the 296 brain of SARS-CoV-2 infected K18 hACE2 transgenic mice also had significant levels of MIP-297 2/CXCL2, IP-10/CXCL10 and MIP-1/CCL3 but in contrast to other organs, these were detectable 298 only at 4-DPI (Fig 2C) , similar to the detection of virus in brain. There were no differences in 299 chemokine levels in the lung between male and female K18 hACE2 transgenic infected mice, with 300 the exception of IP-10/CXCL10 at 2-DPI, which was significantly higher in female K18 hACE2 301 transgenic mice (Fig S5A) . 302 We next determined if SARS-CoV-2 infection of K18 hACE2 transgenic mice resulted in a cytokine 305 storm, as described during the development of severe COVID-19 disease in humans (reviewed 306 in 22-26 ). Multiple tissues were analyzed to define local and systemic inflammatory, TH1, TH17, 307 and TH2 responses. At 2-DPI the cytokine profile in the lungs of K18 hACE2 transgenic mice 308 included a mixed inflammatory (TNF, IL-6, IFN-, and IFN-), TH1 (IL-12, IFN-), TH17 (IL-17, IL-309 27) and TH2 (IL-4, IL-10) profile (Fig 3A) . Notably, IL-1 production was absent at 2-and 4-DPI. 310 Reports in humans with COVID-19 showed that IL-1 precedes other cytokine production 26,27 311 Thus, studying earlier time points may have been informative in this mouse model with regard to 312 IL-1 production. 313 314 Similar to that observed for chemokines, the cytokine storm resolved by 4-DPI with the exception 315 of TNF and the type I and III IFNs which remained significantly increased when compared to 316 SARS-CoV-2 infected C57BL/6 WT or mock-infected K18 hACE2 transgenic mice (Fig 3A) . 317 Reduction of chemokines and cytokines occurred despite increasing viral loads and extensive 318 weight loss in virus-infected K18 hACE2 transgenic mice. No significant sex differences were 319 found for cytokine levels in the lung (data not shown). 320 With few exceptions, the cytokine storm was absent in the spleen (Fig 3B) , nasal turbinate (Fig 322 S4A ), and trachea (Fig S4B) of SARS-CoV-2 infected K18 hACE2 transgenic mice, indicating 323 that the cytokine response was relatively localized to the lung. Exceptions included an increase 324 in TNF at 2-DPI in the spleen (Fig 3B) , and a moderate but significant increase in IL-10 in the 325 nasal turbinate at 2-DPI (Fig S4A) . Interestingly, although we observed decreased cytokines in 326 the lung by 4-DPI, some TH1 and TH17 cytokines (Fig 3C) and chemokines (Fig 2C) increased 327 in the brain at this same time-point, suggesting a delayed viral spread to the brain. IL-1, IL-27, 328 IL-4, IL-13 and IL-10 were also elevated in the brain of C57BL/6 WT mice infected with SARS-329 CoV-2, even in the absence of detectable virus in any organs. IFN- (type I) was not detected in 330 the brain of SARS-CoV-2-infected K18 hACE2 transgenic or WT C57BL/6 mice. However, both 331 IFN- (type II) and IFN- (type III) were lower in K18 hACE2 transgenic mice relative to WT 332 C57BL/6 mice infected with SARS-CoV-2, and similar to mock-infected K18 hACE2 transgenic 333 mice (Fig 3C) . 334 335 A clear sex difference was observed in the brain. Males had significantly higher TH1 and TH17 336 cytokine responses at 4-DPI compared to SARS-CoV-2 infected female K18 hACE2 transgenic 337 mice, and female mice had significantly higher TH2 responses when compared to male K18 338 hACE2 transgenic mice at the same time point (Fig S5B) . These sex differences are similar to 339 studies of acute LPS-induced inflammation. 28,29 The TH1/TH2 sex difference was not observed in 340 C57BL/6 WT mice infected with SARS-CoV-2 (Fig S5B) . The IL-10 cluster (Cluster-1) was also observed in the spleen at 2-DPI, correlating with IL-6 (0.96), 357 IL-4 (0.95), IL-13 (0.93) and IL-1 (0.88); and at 4-DPI, correlating with IL-13 (0.92), IL-4 (0.89) 358 and IL-1 (0.76)] (Fig 4B) , but not in the brain (Fig 4C) . Indeed, in the brain a correlation between 359 IL-2, IL-4 and IL-13 was observed independent of IL-10 at 2-DPI (Cluster-4, Fig 4C) . In the brain, 360 a larger cluster (Cluster 5) was observed at 4-DPI, driven by RANTES/CCL5 and correlating with 361 all MCP-1/CCL2, MIP-1/CCL3, TNF (0.99) and IL-6 (0.98) (Fig 4C) . Nasal turbinate and trachea 362 did not have significantly elevated levels of cytokines and chemokines (Fig S6 A, B) . 363 364 When analyzed by sex, Cluster-1 (Fig 4A) had perfect correlations in males at 2-DPI but these 365 correlations were absent in females with the exception of the IL-4 correlation with IL-10 (0.95) 366 ( Fig S7A) . Cluster-2 in males at 2-DPI did not extend to 4-DPI for either sex (Fig S7B) . Indeed, 367 at 4-DPI in males, a new Cluster-9 with correlations between TNF, MCP-1/CCL2 and MIP-368 1/CCL3 together with IL-12p70 and MIP-2/CXCL2 was observed (Fig S7B) . 369 In the brain, RANTES/CCL5, MIP-1/CCL3 and IL-10 correlated with SARS-CoV-2 viral load in 371 the nasal turbinate at 2-DPI only in males (Fig S7C) . This correlation disappeared at 4-DPI but a 372 correlation between SARS-CoV-2 viral load and IL-10 in the brain was then observed (Fig S7D) . 373 Conversely, SARS-CoV-2 viral load in the brain positively correlated with the presence of 374 chemoattractants [MIP-2/CXCL2, IP-10/CXCL10, MCP-1/CCL2 and MIP-1/CCL3] in females 375 ( Fig S7D) . All correlated with the presence of RANTES/CCL5 and TNF in the brain, as well as 376 with SARS-CoV-2 viral titers in nasal turbinate (Fig S7D) . aggregates in the lamina propria of the small intestine (Fig 5I, asterisk) and few small aggregates 386 of mixed mononuclear inflammation with few neutrophils occasionally admixed with individual 387 hepatocellular necrosis (Fig 5J, arrowhead) . Minimal alveolar histiocytosis (Fig 5D, asterisk) , 388 pneumocyte type II cells (Fig 5D, arrowheads) , perivascular mononuclear inflammation (Fig 5D, 389 bracket) and rhinitis with low numbers of neutrophils (Fig 5K, arrowhead) were variably 390 observed in 4-DPI WT C57BL/6 mice (Fig 5D) . Brain tissue from SARS-CoV-2-infected C57BL/6 391 WT mice 4-DPI was normal (Fig 5L) . Thus, WT C57BL/6 mice had minimal to no pathologic 392 findings consistent with their undetectable viral loads. variable amounts of individual hepatocellular necrosis (Fig 5N, arrowhead) , as well as gut 400 associated lymphoid tissue (GALT) with prominent centers (Fig 5M, asterisk) . By 4-DPI, the 401 majority of K18 hACE2 transgenic mice had 25% or greater lung involvement indicative of 402 pneumonia (Fig 5G) , with affected areas presenting with inflammatory cellular accumulations and 403 hemorrhage in alveolar spaces (Fig 5H, asterisk) and interstitium (Fig 5H, bracket) , intra-404 alveolar fibrin admixed cellular debris (Fig 5H, arrow) , vasculitis (Fig 5H, bracket) , edema (Fig 405 5H, arrowhead) , and neutrophilic rhinitis (Fig 5O, bracket) . By 4-DPI, K18 hACE2 transgenic 406 mice had inflammation in the liver (not shown), and lymphocyte and neutrophil aggregates in the 407 small intestine (not shown). Two K18 hACE2 transgenic mice had evidence of cerebral pathology; 408 one animal had perivascular hemorrhage (not shown) and another animal had mild 409 meningoencephalitis with vasculitis (Fig 5P, arrowhead) . distribution of viral NP in the lungs of K18 hACE2 transgenic mice; however, this distribution was 415 more focalized in the nasal turbinate (Fig 6A) . Virus NP antigen was undetectable in all organs 416 from C57BL/6 WT-infected mice (Fig 6A) . Distribution of the hACE2 receptor by IHC was obvious 417 in the lungs and in the epithelium of the nasal turbinate of K18 hACE2 transgenic mice (Fig 6A) 418 and, as expected, absent from C57BL/6 WT mice (Fig 6A) . Viral NP antigen did not co-localize 419 in the same regions as hACE2 except in the lung ( Fig. 6A and data not shown) perhaps because 420 necropsies were first performed at 2-DPI. hACE2 was also highly expressed in the choroid plexus 421 and some cells were also positive for SARS-CoV-2 NP (Fig 6B) . Herein we demonstrate that K18 hACE2 transgenic mice are highly susceptible to SARS-CoV-2 434 infection, quickly reaching study endpoints by 6-DPI following i.n. infection with 10 5 PFU. SARS-435 CoV-2 was detected in the nasal turbinate and lung of K18 hACE2 transgenic mice on 2-and 4-436 DPI, and in the brain at 4-DPI. The existence of SARS-CoV-2 in the lung, nasal turbinate and 437 brain of SARS-CoV-2-infected hACE2 transgenic mice was verified by the presence of NP antigen 438 using IHC, although NP antigen did not generally co-localize with hACE2 protein expression 439 except in lungs, perhaps because SARS-CoV-2 had already entered the epithelium of the nasal 440 The consequences of reduced cytokine production at 4-DPI is unknown but we can speculate on 504 several modes of action. This process could be driven by accumulation of lymphoid tissue around 505 the airways, which dampens initial responses in severe influenza virus infection. 38 Alternatively, 506 there may be a reestablishment of the balance between pro-inflammatory cytokines and their 507 soluble receptors or inhibitors in the alveolar compartment. 39 The production of TH2 cytokines 508 also represents another mechanism involved in regulating pro-inflammatory responses. The 509 observed production of IL-10, although commonly recognized as an anti-inflammatory cytokine, 510 plays a role in fibrosis, inducing collagen production and fibrocyte recruitment into the lung. 34, 40 In 511 this context, several correlative cytokine clusters linked by IL-10 were observed in multiple organs 512 including the lungs and the brain. Elevated IL-10 can be associated with immune paralysis, 34 513 altering the function of neutrophils and monocytes reaching the local infection site, potentially 514 driving the expansion of the SARS-CoV-2 infection in the K18 hACE2 transgenic mouse model. 515 Alternatively, the high levels of IL-6 observed in tissues may provide a mechanism for enhancing 516 TNF activity during acute viral infection, 39 as well as B cell antibody production and fibrosis. 41 517 Thus it is conceivable that if one or more of these regulatory mechanisms are aberrantly regulated 518 or absent, the pro-and anti-inflammatory balance critical for lung immune homeostasis might be 519 disrupted, contributing to the cytokine storm observed in the K18 hACE2 transgenic mouse model 520 upon SARS-CoV-2 infection. Interestingly, IL-4/IL-13 activation of the STAT-6 signaling pathway 521 is associated with some lung pathologies including asthma. 42,43 The IL-6/IL-10/IL-13 correlation 522 has also been described in patients with viral infections, where their expression levels in serum 523 correlates with the disease clinical state, 44 as well as to aortic aneurysm. 45 Indeed, influenza 524 infection is related to heart pathologies. 46 525 526 Although SARS-CoV-2 was detected in the brain at 4-DPI, minimal histopathological changes 527 were observed for the majority of mice, except for two mice that presented with multifocal 528 perivascular neutrophils, lymphocytes, microglial cells and necrotic debris, vasculitis, and 529 inflammation that extended to the meninges with hemorrhage. Brain cytokine responses were 530 dominated by TH2 cytokines (IL-4, IL-13, IL-10, IL-27, and IL-33) which may reflect the natural 531 TH2 status of the brain. 47,48 IL-27 is known to regulate inflammation in the CNS through 532 upregulation of IL-10, 49-51 but can also potentiate inflammation through induction of IL-12. 52 The 533 cytokine profiles observed in SARS-CoV-2 infected mice suggest it is the former response at play, 534 working to counterbalance the potent peripheral TH1 responses. We also observed increases in 535 cytokine production at 2-and 4-DPI that included a robust IL-1 response. The detection of IL-1 536 in brain at 2-DPI suggests that virus spread to brain was delayed relative to lung and spleen 27 . 537 Interferon type II and III were significantly lower in the brain of SARS-CoV-2 infected K18 hACE2 538 transgenic mice when compared to WT C57BL/6 mice at all-time points studied, and interferon 539 type I was not detected, which could be a deciding factor driving colonization of the brain by 540 SARS-CoV-2 in this mouse model. Indeed, deviation from homeostatic IFN type I/IFN type II 541 balance contributes to insufficient immune surveillance of the CNS and loss of immune-dependent 542 protection, or immune-mediated destruction. 53 543 544 Most intriguing was that many TH2 cytokines (IL-1, IL-27, IL-4, IL-13, IL-33 and IL-10) were also 545 elevated in the brain of WT C57BL/6 control mice at 2-and 4-DPI. Although we did not find any 546 virus in WT C57BL/6 mice, it suggests that the virus might be privy to the blood brain barrier 547 because the cytokine pattern in the brain was similar to K18 hACE2 transgenic mice. C57BL/6 548 mice express the mouse ACE2 protein and studies have shown that ACE2 gene-disrupted mice 549 are less susceptible to SARS-CoV-1. 54 Therefore, it is possible that endogenous ACE2 in mice 550 could drive a cytokine response in the brain of WT C57BL/6 mice infected with SARS-CoV-2 while 551 showing very limited peripheral responses. Overall, these data suggest that there may be some 552 tropism for SARS-CoV-2 in the brain of WT mice, supporting some reports of neurological issues 553 in humans with COVID-19. 55 We also observed sex differences in K18 hACE2 transgenic mice 554 with males exhibiting a TH1 and TH17 phenotype at 4-DPI whereas female K18 hACE2 555 transgenic mice had a TH2 responses at the same time point, similar to studies of acute LPS-556 induced inflammation, 28,29 which suggests that males may be more prone to exhibit neurological 557 problems during SARS-CoV-2 infection, independent of viral load. 558 559 While our findings clearly identify the K18 hACE2 transgenic mouse as a model for SARS-CoV-2 560 infection and COVID-19 disease, our studies have some limitations. The primary limitation was 561 the number of mice that were available for study, due to limited supply from the vendor. We 562 maximized our studies by performing two independent experiments that cross-validated each 563 other in survival and pathogenesis results. Both studies showed considerable sensitivity of K18 564 hACE2 transgenic mice to SARS-CoV-2 infection. We chose a relatively high viral dose (MOI 565 1x10 5 PFU/mouse) that was capable of causing extensive disease, but we were unable to include 566 additional time points to further understand the time course of immune responses (e.g. 1-DPI) or 567 whether the chemokine and cytokine storm increased again at study endpoints (e.g. 5/6-DPI). We would like to thank all members of Texas Biomedical Research Institute for their efforts in 598 keeping the institute fully operational during the COVID-19 pandemic, making this study possible. 599 We would also like to thank the support of Texas Biomed donors, whose COVID-19 philanthropic 600 donations made possible the realization of this study. We thank Dr. Abul Azad for his assistance 601 with editing. Finally, we would also like to thank The Jackson Laboratory, especially Drs. Cat Lutz 602 and Steve Rockwood, for providing us with K18 hACE2 transgenic mice to conduct this study; 603 and the Texas Biomed IACUC and BSC committees and EHS for their attention to review our 604 protocols in a time efficient manner to facilitate rapid sharing of our data with the scientific 605 community. We would like to dedicate this manuscript to all COVID-19 victims and to all heroes 606 battling this disease.  Regional perivascular edema admixed with mononuclear inflammation (1 M). CONTROLS: WT 57BL/6 and K18 hACE2 transgenic mock infected mice were assessed at the completion of the study, and showed no significant, or mild, microscopic lesions. Specifically, WT C57BL/6 mock infected mice has no significant lesions, with the exception of prominent lymphoid follicles within the lamina propria (GALT) and spleenic white pulp (1M), or small lymphocyte aggregates admixed with few neutrophils in the hepatic sinusoids (1F). K18 ACE2 transgenic mock infected mice had minor findings; two small focal perivascular aggregates of lymphocytes, few small lymphocyte aggregates, and focal osseous metaplasia within the pleura; few small aggregates of histiocytes and lymphocytes admixed with few neutrophils within hepatic sinusoids and occasionally in portal triads; prominent lymphoid follicles within gastrointestinal lamina propria (M); and macrophages within the splenic red pulp with minimal yellow intracytoplasmic pigment (1F). female (N=4/group) mice were infected as in Figure S1 and sacrificed at 2-and 4-DPI and viral 922 titers in different organs (nasal turbinate, trachea, lung, brain, heart, kidney, liver, spleen, small 923 intestine, and large intestine) were determined by plaque assay (PFU/ml). Only data from virus 924 containing organs and/or tissue samples are shown: nasal turbinate (A), lungs (B) and brain (C). K18 hACE2 transgenic and WT C57BL/6 female and male mice were mock-infected (N=3/group) or infected i.n. (N=4/group) with 1 x 10 5 PFU of SARS-CoV-2. Body weight (A) and survival (B) were evaluated at the indicated DPI. Mice that loss more than 25% of their initial body weight were humanely euthanized. Error bars represent standard deviations (SD) of the mean for each group of mice. (C-E) K18 transgenic hACE2 and WT C57BL/6 male (N=3) and female (N=3) mice were similarly infected and sacrificed at 2 and 4 DPI and viral titers in different organs (nasal turbinate, trachea, lung, brain, heart, kidney, liver, spleen, small intestine, and large intestine) were determined by plaque assay (PFU/ml). Data from virus containing organs and/or tissue samples are shown: nasal turbinates (C), lungs (D) and brain (E). Symbols represent data from individual mouse, and bars the geometric means of viral titers. ND, not detected. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is 642 Blocked by a Clinically Proven Protease Inhibitor Genomic characterisation and epidemiology of 2019 novel coronavirus: 645 implications for virus origins and receptor binding Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Structural basis for the recognition of SARS-CoV-2 by full-length human Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and 652 Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery 653 of ACE2 Clinical course and risk factors for mortality of adult inpatients with China: a retrospective cohort study Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Covid-19 Does Not Lead to a "Typical COVID-19 pneumonia: ARDS or not? Lethal infection of K18-hACE2 mice infected with severe acute 667 respiratory syndrome coronavirus Evaluation of K18-669 hACE2 mice as a model of SARS-CoV-2 infection Mouse Models for SARS-CoV-2 Infection Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human 676 Angiotensin-Converting Enzyme 2 A mouse model 680 of SARS-CoV-2 infection and pathogenesis The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by 685 Mouse model of SARS-CoV-2 reveals inflammatory role of type I 687 interferon signaling. bioRxiv Generation of a Broadly Useful Model for COVID-19 Pathogenesis Mucosal vaccination with attenuated Mycobacterium tuberculosis 691 induces strong central memory responses and protects against tuberculosis CD4+ T-cell-independent mechanisms suppress reactivation of 694 latent tuberculosis in a macaque model of HIV coinfection The cytokine storm in 697 COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system Cytokine storm induced by SARS-CoV-2 SARS-CoV-2 infection: The role of cytokines in COVID-19 disease The pathogenesis and treatment of the `Cytokine Storm Viral and host factors related to the clinical outcome of COVID-19 A Dynamic Immune Response Shapes COVID-19 Progression Sex differences in hippocampal cytokines after systemic immune 711 challenge Sex differences in the hippocampal cytokine response 713 following systemic lipopolysaccharide Reduced inflammation and improved airway expression using helper-716 dependent adenoviral vectors with a K18 promoter Cg-Tg(K18-ACE2)2Prlmn/J -K18 hACE2 mouse -719 Jing Xue; Shuran Gong The Pathogenicity of 2019 Novel Coronavirus in 726 hACE2 Transgenic Mice Influenza 728 seasonality: underlying causes and modeling theories Into the eye of the cytokine storm Human infection by avian influenza A H5N1. Hong Kong Med 733 J 11 An interferon-gamma-related cytokine storm in SARS patients Interferon-mediated immunopathological events are associated 737 with atypical innate and adaptive immune responses in patients with severe acute respiratory 738 syndrome Role of inducible bronchus associated lymphoid tissue 740 (iBALT) in respiratory immunity Cytokine balance in the lungs of patients with acute respiratory distress 742 syndrome New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 745 activation in a CCL2/CCR2 axis The biology and medical implications of interleukin-6 Analysis of changes in expression of IL-4/IL-13/STAT6 pathway and 750 correlation with the selected clinical parameters in patients with atopic asthma Tuning the Cytokine Responses: An Update on Interleukin IL-6, IL-10 and IL-13 are associated with pathogenesis in children with Enterovirus 71 infection Upregulated interleukins (IL-6, IL-10, and IL-13) in immunoglobulin G4-related aortic aneurysm patients IFITM3 protects the heart during influenza virus infection Regulation of Th1 and Th2 lymphocyte 762 migration by human adult brain endothelial cells IL-4 in the brain: a cytokine to 765 remember IL-27 limits central nervous system viral clearance by promoting 767 IL-10 and enhances demyelination The immunobiology of interleukin-27 Interleukin-10 in the brain Interleukin-27 promotes 773 inflammatory and neuroprotective responses in microglia Type I/II Interferon Balance in the 776 Regulation of Brain Physiology and Pathology A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS 779 coronavirus-induced lung injury New insights into the neurological effects of COVID-19 Structure of the SARS-CoV-2 spike receptor-binding domain bound to the 783 ACE2 receptor Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Structural and Functional Basis of SARS-CoV-2 Entry by Using Human Structural basis of receptor recognition by SARS-CoV-2 DNA vaccine protection against SARS-CoV-2 in rhesus macaques SARS-CoV-2 infection protects against rechallenge in rhesus 794 macaques SARS-CoV-2 infection leads to 803 acute infection with dynamic cellular and inflammatory flux in the lung that varies across 804 nonhuman primate species STAT2 signaling as 810 double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-811 2 infected hamsters Simulation of the clinical and pathological manifestations of 814 COVID-19) in golden Syrian hamster model: implications for 815 disease pathogenesis and transmissibility Pathogenesis and transmission of SARS-CoV-2 virus in golden Syrian hamsters Type I interferon limits influenza virus-induced acute lung injury by 820 regulation of excessive inflammation in mice IFNAR2 Is Required for Anti-influenza Immunity and Alters 823 Susceptibility to Post-influenza Bacterial Superinfections ** *** **